310 related articles for article (PubMed ID: 38724973)
1. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
[TBL] [Abstract][Full Text] [Related]
2. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
[TBL] [Abstract][Full Text] [Related]
3. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
[TBL] [Abstract][Full Text] [Related]
4. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
[TBL] [Abstract][Full Text] [Related]
5. Future prospects for regenerated heart using induced pluripotent stem cells.
Fujita J; Fukuda K
J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
Easley CA
Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
Shtrichman R; Germanguz I; Itskovitz-Eldor J
Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
[TBL] [Abstract][Full Text] [Related]
8. Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.
Paik DT; Chandy M; Wu JC
Pharmacol Rev; 2020 Jan; 72(1):320-342. PubMed ID: 31871214
[TBL] [Abstract][Full Text] [Related]
9. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
[TBL] [Abstract][Full Text] [Related]
10. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
11. Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease.
Chun YS; Chaudhari P; Jang YY
Int J Biol Sci; 2010 Dec; 6(7):796-805. PubMed ID: 21179587
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
13. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
14. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
Cong X; Zhang SM; Ellis MW; Luo J
Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
[TBL] [Abstract][Full Text] [Related]
15. Human iPSC banking: barriers and opportunities.
Huang CY; Liu CL; Ting CY; Chiu YT; Cheng YC; Nicholson MW; Hsieh PCH
J Biomed Sci; 2019 Oct; 26(1):87. PubMed ID: 31660969
[TBL] [Abstract][Full Text] [Related]
16. Recent technological updates and clinical applications of induced pluripotent stem cells.
Diecke S; Jung SM; Lee J; Ju JH
Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
[TBL] [Abstract][Full Text] [Related]
17. Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
Pan Z; Ebert A; Liang P
Pflugers Arch; 2021 Jul; 473(7):1151-1165. PubMed ID: 33206225
[TBL] [Abstract][Full Text] [Related]
18. The march of pluripotent stem cells in cardiovascular regenerative medicine.
Abou-Saleh H; Zouein FA; El-Yazbi A; Sanoudou D; Raynaud C; Rao C; Pintus G; Dehaini H; Eid AH
Stem Cell Res Ther; 2018 Jul; 9(1):201. PubMed ID: 30053890
[TBL] [Abstract][Full Text] [Related]
19. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
